Keynumbers for: Biotech-IgG

 6/30/201012/31/20106/30/201112/31/20116/30/201212/31/20126/30/201312/31/2013
Number of months that the report spans612612612612
Total revenue (MSEK)7.1812.622.634.901.342.711.123.76
Earnings before interest and taxes (EBIT) (MSEK)-2.93-4.46-1.50-7.30-1.38-3.36-2.23-3.83
Pre tax profit (PTP) (MSEK)-2.93-4.46-1.66-7.42-1.38-3.35-2.23-3.83
Net Revenue (MSEK)-3.01-5.16-1.70-7.40-1.38-3.39-2.21-3.82
Earnings per share (SEK)-0.41-0.53-0.16-0.62-0.07-0.09-0.03-0.05
Dividend per share (SEK)--------
Owner's equity (MSEK)6.316.736.802.882.972.752.711.94
Fixed assets (MSEK)4.974.874.741.260.620.330.510.35
Intangible assets (MSEK)--3.850.610.550.290.230.17
Liquid assets (MSEK)6.244.35-2.853.223.363.023.04
Total shareholder equity and liabilities (MSEK)--8.584.123.843.693.533.38
Long time debts including distributions (MSEK)0.90--0.11-0.030.01-
Short term debt (MSEK)4.892.481.781.130.870.910.811.44
The share's par value (SEK)1.001.001.00.050.050.050.050.05
Cash flow for the period (MSEK)---0.65-0.590.220.55-0.29-0.68
Number of shares (in millions)--12 320 54814 631 98731 749 40872 717 87578 618 19481 739 684
Average number of employees61111-33

  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se